| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
612 |
558 |
$138K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
531 |
506 |
$93K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
452 |
438 |
$91K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
173 |
170 |
$26K |
| 70450 |
Computed tomography, head or brain; without contrast material |
167 |
164 |
$23K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
76 |
72 |
$12K |
| 59025 |
Fetal non-stress test |
36 |
30 |
$12K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
71 |
71 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
54 |
54 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
444 |
428 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
314 |
306 |
$9K |
| 62323 |
|
12 |
12 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
33 |
33 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
616 |
304 |
$6K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
33 |
29 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
35 |
35 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
122 |
111 |
$5K |
| ATP14 |
|
449 |
413 |
$5K |
| 76830 |
Ultrasound, transvaginal |
65 |
65 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
15 |
15 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
131 |
129 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
849 |
731 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
84 |
83 |
$4K |
| 76642 |
|
57 |
47 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
31 |
30 |
$3K |
| 76536 |
|
41 |
41 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
43 |
43 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
31 |
12 |
$2K |
| S9485 |
Crisis intervention mental health services, per diem |
14 |
14 |
$2K |
| G0378 |
Hospital observation service, per hour |
91 |
46 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
72 |
63 |
$2K |
| 84484 |
|
353 |
188 |
$2K |
| 71250 |
|
20 |
20 |
$2K |
| 77062 |
|
33 |
31 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
16 |
16 |
$1K |
| 84702 |
|
116 |
104 |
$1K |
| 72110 |
|
40 |
40 |
$1K |
| ATP08 |
|
138 |
130 |
$1K |
| 73562 |
|
60 |
54 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
79 |
78 |
$1K |
| 93017 |
|
13 |
13 |
$988.16 |
| 81025 |
|
143 |
135 |
$903.21 |
| 83690 |
|
143 |
138 |
$784.32 |
| 77066 |
Tomosynthesis, mammo |
33 |
31 |
$740.80 |
| 72100 |
|
31 |
31 |
$697.77 |
| 73130 |
|
35 |
32 |
$697.76 |
| 93971 |
|
17 |
17 |
$692.95 |
| 72131 |
|
16 |
16 |
$686.42 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
106 |
104 |
$683.52 |
| 73630 |
|
33 |
31 |
$658.99 |
| 77061 |
|
15 |
13 |
$648.13 |
| 86850 |
|
78 |
74 |
$629.26 |
| 77065 |
Tomosynthesis, mammo |
20 |
17 |
$601.87 |
| 73030 |
|
50 |
49 |
$542.70 |
| 81001 |
|
217 |
214 |
$534.80 |
| 71045 |
Radiologic examination, chest; single view |
84 |
82 |
$527.68 |
| 84703 |
|
95 |
92 |
$523.77 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
43 |
43 |
$490.30 |
| 80050 |
General health panel |
37 |
35 |
$458.90 |
| 83880 |
|
14 |
14 |
$450.06 |
| ATP15 |
|
40 |
40 |
$442.26 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
46 |
43 |
$440.50 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$433.16 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$433.16 |
| 83735 |
|
87 |
72 |
$419.61 |
| 87807 |
|
38 |
38 |
$392.70 |
| 81003 |
|
224 |
216 |
$366.30 |
| 87081 |
|
65 |
64 |
$333.45 |
| 73610 |
|
39 |
38 |
$310.12 |
| 85379 |
|
32 |
31 |
$260.42 |
| 83605 |
|
28 |
26 |
$244.80 |
| 86901 |
|
81 |
77 |
$200.64 |
| 86900 |
|
81 |
77 |
$200.64 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
364 |
330 |
$169.35 |
| 76801 |
|
51 |
47 |
$160.19 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
47 |
38 |
$152.72 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
157 |
138 |
$152.72 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$148.20 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
62 |
56 |
$137.90 |
| 85610 |
|
42 |
40 |
$132.30 |
| 88304 |
|
13 |
13 |
$118.20 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
242 |
233 |
$107.29 |
| 82947 |
|
92 |
71 |
$100.63 |
| 87077 |
|
17 |
16 |
$99.82 |
| 85027 |
|
17 |
17 |
$91.36 |
| ATP02 |
|
15 |
13 |
$84.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
242 |
216 |
$75.20 |
| 80053 |
Comprehensive metabolic panel |
599 |
538 |
$74.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
131 |
122 |
$71.53 |
| 85730 |
|
12 |
12 |
$58.30 |
| 85652 |
|
15 |
12 |
$23.80 |
| 82565 |
|
32 |
32 |
$4.52 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
38 |
34 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
97 |
71 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
41 |
40 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
42 |
34 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
22 |
22 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
146 |
134 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
193 |
178 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
87 |
53 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
13 |
$0.00 |
| 88342 |
|
17 |
15 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
46 |
31 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
25 |
22 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14 |
13 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
146 |
126 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
59 |
50 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
23 |
21 |
$0.00 |
| 80076 |
|
30 |
29 |
$0.00 |
| 84520 |
|
32 |
32 |
$0.00 |
| 76376 |
|
13 |
13 |
$0.00 |